agatoxin-489 has been researched along with sr141716 in 1 studies
Studies (agatoxin-489) | Trials (agatoxin-489) | Recent Studies (post-2010) (agatoxin-489) | Studies (sr141716) | Trials (sr141716) | Recent Studies (post-2010) (sr141716) |
---|---|---|---|---|---|
6 | 0 | 1 | 2,229 | 60 | 631 |
Protein | Taxonomy | agatoxin-489 (IC50) | sr141716 (IC50) |
---|---|---|---|
Bile salt export pump | Homo sapiens (human) | 10 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.0069 | |
Cannabinoid receptor 1 | Rattus norvegicus (Norway rat) | 0.0081 | |
Cannabinoid receptor 1 | Homo sapiens (human) | 0.0219 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.0069 | |
Cannabinoid receptor 2 | Homo sapiens (human) | 2.4666 | |
Cannabinoid receptor 1 | Mus musculus (house mouse) | 0.025 | |
Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.108 | |
Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.795 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alger, BE; Kim, J | 1 |
1 other study(ies) available for agatoxin-489 and sr141716
Article | Year |
---|---|
Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses.
Topics: Agatoxins; Animals; Arachidonic Acids; Benzamides; Benzoxazines; Biophysics; Calcium; Calcium Channel Blockers; Cannabinoid Receptor Modulators; Carbamates; Conotoxins; Dose-Response Relationship, Drug; Down-Regulation; Drug Interactions; Electric Stimulation; Endocannabinoids; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; gamma-Aminobutyric Acid; Glycerides; Hippocampus; Homeostasis; In Vitro Techniques; Inhibitory Postsynaptic Potentials; Morpholines; Naphthalenes; Nerve Net; Neural Inhibition; Neurons; Patch-Clamp Techniques; Piperidines; Polyamines; Polyunsaturated Alkamides; Pyrazoles; Rats; Receptor, Cannabinoid, CB1; Rimonabant; Sodium Channel Blockers; Synapses; Tetrodotoxin | 2010 |